Data / Form D filings / IDUN PHARMACEUTICALS INC
IDUN PHARMACEUTICALS INC: Form D filings
IDUN PHARMACEUTICALS INC, a pharmaceuticals company in San Diego, CA, filed 4 Form D notices with the SEC between 2014 and 2015. The latest, on July 13, 2015, reports $1.1 million sold of a $1.5 million offering to 30 investors.
Find out what IDUN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12463 RANCHO BERNARDO RD., #554, San Diego, CA, 92128
- Phone
- (858) 756-2480
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1076413
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2015 | New notice | $1,500,000 | $1,125,000 | $375,000 | 30 | Jul 8, 2015 | sec.gov |
| Feb 4, 2015 | Amendment | $2,000,044 | $2,000,044 | $0 | 30 | Feb 13, 2014 | sec.gov |
| Oct 9, 2014 | Amendment | $500,011 | $500,011 | $0 | 30 | Feb 13, 2014 | sec.gov |
| Feb 25, 2014 | New notice | $275,006 | $275,006 | $0 | 30 | Feb 13, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul F. Klingenstein | Director | |
| Louis F. Lacasse | Director | |
| William F. Gerber, M.D. | Director | |
| Harold O. Van Wart, Ph.D. | Director | |
| Marc O. Perret | Director | |
| Shahzad F. Malik | Director | |
| James O. Scopa | Director | |
| Steven J. Mento, Ph.D. | Director | |
| David F. Hale | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 13, 2015 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IDUN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.